Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people starting Mounjaro notice changes to their skin, including new or worsening acne, while others report clearer skin over time. The relationship between Mounjaro and acne is nuanced: the medicine itself is not listed as a direct cause in the licensed prescribing information, but hormonal and metabolic shifts triggered by significant weight loss can affect the skin in both directions. As a prescription-only medicine, Mounjaro is only available following a thorough clinical assessment by a qualified prescriber, who can weigh up your full medical picture before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Check the official prescribing information and you will not find acne in the side-effect tables. The recognised side effects of tirzepatide are predominantly gastrointestinal: nausea, diarrhoea, constipation, reflux and similar complaints that tend to be most noticeable at the start of treatment or after a dose increase. The NHS tirzepatide medicines page reflects this same profile.
That does not mean skin changes are imaginary. Clinical trials and post-marketing experience capture the most common effects; rarer or indirect effects take longer to surface in the evidence base. What the data tell us is that Mounjaro does not appear to cause acne through any direct mechanism, there is no receptor it activates in the skin that drives breakouts. The more likely explanation, when acne does appear, lies in what the medicine does to the body more broadly.
A question our prescribers hear fairly often is whether a new spot or two signals something more serious. In almost every case, the answer is no, but it is always worth mentioning at your next check-in rather than reading into it alone.
Tirzepatide works by activating both GIP and GLP-1 receptors, reducing appetite and improving how the body handles blood sugar and insulin. As people lose weight (sometimes quite rapidly) the body undergoes significant hormonal recalibration. Androgens, the hormones most closely linked to sebum production and acne, shift during this process. So does cortisol, which can spike temporarily during periods of physiological change.
For some people, particularly in the first few months, this recalibration can trigger mild breakouts, not because Mounjaro and acne are directly connected, but because the body is adjusting. Rapid dietary changes can also play a role: if appetite suppression leads to inconsistent eating patterns or low protein intake, skin health can be affected indirectly. Staying well hydrated and maintaining adequate nutrition matters, and your prescriber can advise on diet alongside treatment.
You can read more about how tirzepatide fits into a broader weight management approach on our Mounjaro treatment overview.
Possibly, and for a specific group, the evidence points that way. Insulin resistance and elevated androgens are central to the skin problems many people with PCOS experience, including persistent hormonal acne. Tirzepatide's ability to improve insulin sensitivity and reduce circulating insulin may, over time, lower androgen activity and reduce the sebum overproduction that feeds acne, and if you want to understand how ace mounjaro fits into this picture our dedicated page walks through the detail.
This is not a licensed indication; Mounjaro is prescribed for weight management, not as an acne treatment. But the metabolic improvements it produces are real, and several dermatology researchers have noted that GLP-1-based medicines warrant closer study in the context of inflammatory skin conditions. For people whose acne has always tracked their weight or cycle, seeing improvement as metabolic health improves is biologically plausible.
If you are curious about whether your situation might make you a suitable candidate for treatment, our weight loss treatment overview sets out the eligibility picture clearly. Cost is a common question too, and our Mounjaro cost page covers what private treatment actually includes.
First, do not stop or adjust your dose because of a skin concern. Titration schedules exist for clinical reasons, and changes should only happen with prescriber involvement, the Patient Information Leaflet and your prescribing team are the right places to go for guidance on your specific situation, not general advice online.
If the breakout is new, mild and appeared within the first few weeks, a watchful approach alongside good skincare is usually reasonable. Many patients find it helpful to read about what to expect at each stage, including our pages covering mounjaro 2 and the step up to mounjaro 5, so they know whether any changes coincide with a dose increase. If the breakout is severe, spreading, or accompanied by other symptoms, contact a dermatologist or your GP. You can also reach the nume team directly through our aftercare support, available seven days a week.
Some people notice other GI-adjacent skin effects too, such as slight changes in how their skin feels during episodes of nausea or reduced food intake. These are worth tracking, and our page on e mounjaro covers some of the broader tolerability questions patients raise between appointments. The MHRA Yellow Card scheme allows patients to report any suspected side effect (including unexpected skin changes) which helps build the broader evidence picture for medicines like tirzepatide that are still under additional MHRA monitoring.
When your prescription is approved, the pen arrives via DPD in plain, unbranded packaging the next working day, tracked to your door. The pen itself is a pre-filled KwikPen; your prescribing team and the enclosed leaflet will walk you through everything before you use it for the first time.
If you have concerns about your skin or want a prescriber to review your full medical picture before starting, the right step is a consultation. Start your free consultation and one of our GPhC-registered prescribers will review your information the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.